Related by context. Frequent words. (Click for all words.) 68 Phase 2b study 66 LymphoStat B 66 denufosol 65 NGX# 65 Phase 2a 65 ISIS # 64 Phase IIa trial 64 HspE7 64 adalimumab 64 daclizumab 64 PRX # 64 Azixa 64 Phase 2b clinical 64 efficacy endpoints 63 ACTEMRA 63 Phase 2a clinical 63 vandetanib 63 bevirimat 63 abatacept 63 ISENTRESS 62 picoplatin 62 Phase 1b 62 LEVADEX 62 Phase IIb clinical 62 Zerenex 62 Phase Ib 62 Phase 2b 62 INCB# [002] 62 CRx 62 MGCD# [001] 62 AZD# 62 Phase IIb trial 62 FOLOTYN 61 ALKS 61 pemetrexed 61 Androxal 61 IMGN# 61 Phase 2b trial 61 rivaroxaban 61 Phase III trials 61 XL# [003] 61 confirmatory Phase 3 61 tolerability profile 61 Phase IIa clinical 61 ASA# 61 Locteron 61 JANUVIA 61 Proellex 61 GATTEX 60 LibiGel 60 FTY# 60 Marqibo 60 ZYBRESTAT 60 ambrisentan 60 certolizumab pegol 60 docetaxel 60 TMC# [001] 60 vilazodone 60 HRPC 60 primary endpoints 60 SPRYCEL 60 RG# [001] 60 plus ribavirin 60 AVONEX 60 tiotropium 60 tamibarotene 60 pivotal Phase III 59 Telaprevir 59 Topical Interferon Alpha 2b 59 PEG INTRON 59 telbivudine 59 RDEA# 59 primary efficacy endpoint 59 peginterferon 59 sunitinib 59 primary endpoint 59 Phase IIa 59 ONCONASE 59 laquinimod 59 pharmacodynamic 59 lubiprostone 59 APF# 59 mipomersen 59 Entereg 59 Alpharadin 59 secondary endpoint 59 Phase IIb 59 belimumab 59 tolerability 59 FOSRENOL 59 mg BID 59 ONGLYZA 59 AP# [003] 59 dose escalation 59 NKTR 59 pharmacokinetic profile 59 dose limiting toxicities 59 SEROQUEL 59 BYDUREON 59 MGCD# [002] 59 T DM1